Literature DB >> 9841733

HIV coreceptors.

D S Dimitrov1, X Xiao, D J Chabot, C C Broder.   

Abstract

Mesh:

Substances:

Year:  1998        PMID: 9841733     DOI: 10.1007/s002329900450

Source DB:  PubMed          Journal:  J Membr Biol        ISSN: 0022-2631            Impact factor:   1.843


× No keyword cloud information.
  12 in total

1.  Cooperation of the V1/V2 and V3 domains of human immunodeficiency virus type 1 gp120 for interaction with the CXCR4 receptor.

Authors:  B Labrosse; C Treboute; A Brelot; M Alizon
Journal:  J Virol       Date:  2001-06       Impact factor: 5.103

2.  Apelin, the natural ligand of the orphan seven-transmembrane receptor APJ, inhibits human immunodeficiency virus type 1 entry.

Authors:  M Cayabyab; S Hinuma; M Farzan; H Choe; S Fukusumi; C Kitada; N Nishizawa; M Hosoya; O Nishimura; T Messele; G Pollakis; J Goudsmit; M Fujino; J Sodroski
Journal:  J Virol       Date:  2000-12       Impact factor: 5.103

3.  Variability in the human immunodeficiency virus type 1 gp120 Env protein linked to phenotype-associated changes in the V3 loop.

Authors:  Noah G Hoffman; Francoise Seillier-Moiseiwitsch; JaeHyung Ahn; Jason M Walker; Ronald Swanstrom
Journal:  J Virol       Date:  2002-04       Impact factor: 5.103

Review 4.  Bioinformatic analysis of HIV-1 entry and pathogenesis.

Authors:  Benjamas Aiamkitsumrit; Will Dampier; Gregory Antell; Nina Rivera; Julio Martin-Garcia; Vanessa Pirrone; Michael R Nonnemacher; Brian Wigdahl
Journal:  Curr HIV Res       Date:  2014       Impact factor: 1.581

5.  Unique monoclonal antibody recognizing the third extracellular loop of CXCR4 induces lymphocyte agglutination and enhances human immunodeficiency virus type 1-mediated syncytium formation and productive infection.

Authors:  R Tanaka; A Yoshida; T Murakami; E Baba; J Lichtenfeld; T Omori; T Kimura; N Tsurutani; N Fujii; Z X Wang; S C Peiper; N Yamamoto; Y Tanaka
Journal:  J Virol       Date:  2001-12       Impact factor: 5.103

6.  Mutagenesis of CXCR4 identifies important domains for human immunodeficiency virus type 1 X4 isolate envelope-mediated membrane fusion and virus entry and reveals cryptic coreceptor activity for R5 isolates.

Authors:  D J Chabot; P F Zhang; G V Quinnan; C C Broder
Journal:  J Virol       Date:  1999-08       Impact factor: 5.103

7.  N-linked glycosylation of CXCR4 masks coreceptor function for CCR5-dependent human immunodeficiency virus type 1 isolates.

Authors:  D J Chabot; H Chen; D S Dimitrov; C C Broder
Journal:  J Virol       Date:  2000-05       Impact factor: 5.103

8.  Identification of a subset of human immunodeficiency virus type 1 (HIV-1), HIV-2, and simian immunodeficiency virus strains able to exploit an alternative coreceptor on untransformed human brain and lymphoid cells.

Authors:  Samantha J Willey; Jacqueline D Reeves; Richard Hudson; Koichi Miyake; Nathalie Dejucq; Dominique Schols; Erik De Clercq; Jeanne Bell; Aine McKnight; Paul R Clapham
Journal:  J Virol       Date:  2003-06       Impact factor: 5.103

Review 9.  HIV envelope: challenges and opportunities for development of entry inhibitors.

Authors:  Michael Caffrey
Journal:  Trends Microbiol       Date:  2011-03-04       Impact factor: 17.079

Review 10.  Receptor binding domain based HIV vaccines.

Authors:  Huan Liu; Wenwen Bi; Qian Wang; Lu Lu; Shibo Jiang
Journal:  Biomed Res Int       Date:  2015-01-15       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.